Mark Adams
Table of Contents show
About BioShin
BioShin is a clinical-stage biopharmaceutical company focused on developing medicines for the Asia-Pacific region.
Website: Learn more on BioShin’s website
Crunchbase: Follow on Crunchbase
[adace-ad id=”4426″]Series A – BioShin
| Amount Raised | 60000000 USD |
| Announced Date | 2020-09-28 |
| Equity Only Funding | Yes |
| Organization Location | Shanghai, Shanghai, China, Asia |
| Funding Status | Early Stage Venture |
| Number of Funding Rounds | 1 |
| Lead Investors | OrbiMed |
| Number of Investors | 5 |
| Number of Partner Investors | 1 |
